Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study
暂无分享,去创建一个
N. Tomita | E. Oki | T. Yamanaka | Y. Kakeji | Y. Maehara | K. Shirabe | H. Saeki | Y. Ogata | H. Baba | H. Kojima | Y. Miyake | Y. Sakaguchi | H. Ishida | M. Kon | T. Kono | Takeshi Kato | Jun Higashijima | Y. Emi | Kenichi Takahashi
[1] Y. Uezono,et al. Goshajinkigan, a traditional Japanese medicine, prevents oxaliplatin-induced acute peripheral neuropathy by suppressing functional alteration of TRP channels in rat. , 2014, Journal of pharmacological sciences.
[2] C. Loprinzi,et al. Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance). , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Yi Zhou,et al. Ca/Mg infusions for the prevention of oxaliplatin-related neurotoxicity in patients with colorectal cancer: a meta-analysis. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] J. Ouyang,et al. Infusion of calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in colorectal cancer: a systematic review and meta-analysis. , 2012, European journal of cancer.
[5] R. Oishi,et al. Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents. , 2012, European journal of cancer.
[6] J. Kigawa,et al. Objective evaluation of the alleviating effects of Goshajinkigan on peripheral neuropathy induced by paclitaxel/carboplatin therapy: A multicenter collaborative study. , 2012, Experimental and therapeutic medicine.
[7] K. Kumamoto,et al. Discrepancy between the NCI-CTCAE and DEB-NTC scales in the evaluation of oxaliplatin-related neurotoxicity in patients with metastatic colorectal cancer , 2012, International Journal of Clinical Oncology.
[8] P. Novotny,et al. Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] J. Watari,et al. Efficacy of Goshajinkigan for Peripheral Neurotoxicity of Oxaliplatin in Patients with Advanced or Recurrent Colorectal Cancer , 2011, Evidence-based complementary and alternative medicine : eCAM.
[10] R. Pearson,et al. Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer , 2010 .
[11] T. Yano,et al. Oxaliplatin-induced neuropathy in the rat: Involvement of oxalate in cold hyperalgesia but not mechanical allodynia , 2009, PAIN®.
[12] J. Sakamoto,et al. Preventive effect of goshajinkigan on peripheral neurotoxicity of FOLFOX therapy: a placebo-controlled double-blind randomized phase II study (the GONE Study). , 2009, Japanese journal of clinical oncology.
[13] U. Jaehde,et al. Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity , 2009, Anti-cancer drugs.
[14] Tetsuya Imamura,et al. Gosha‐jinki‐gan reduces transmitter proteins and sensory receptors associated with C fiber activation induced by acetic acid in rat urinary bladder , 2008, Neurourology and urodynamics.
[15] C. Tournigand,et al. Oxaliplatin-related neurotoxicity: interest of calcium-magnesium infusion and no impact on its efficacy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] C. Fuchs,et al. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] Marc Peeters,et al. Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] B. Djulbegovic,et al. Use of Calcium and Magnesium Salts to Reduce Oxaliplatin-Related Neurotoxicity , 2007 .
[19] H. Adelsberger,et al. Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: Final results of a randomised, controlled, multicenter phase II study , 2006, Investigational New Drugs.
[20] M. Dong. OPTIMOX1:A Randomized Study of FOLFOX4 or FOLFOX7 with Oxaliplatin in A Stop-and-Go Fashion in Advanced Colorectal Cancer——A GERCOR Study , 2006 .
[21] Ma Dong,et al. Bevacizumab plus Irinotecan,Fluorouracil,and Leucovorin for Metastatic Colorectal Cancer , 2006 .
[22] Yuzo Sato,et al. Effects of Goshajinkigan on insulin resistance in patients with type 2 diabetes. , 2005, Diabetes research and clinical practice.
[23] Y. Oshida,et al. Gosha-jinki-gan (a Herbal Complex) Corrects Abnormal Insulin Signaling , 2004, Evidence-based complementary and alternative medicine : eCAM.
[24] N. Ifrah,et al. Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium Infusions , 2004, Clinical Cancer Research.
[25] T. Hickish,et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. , 2004, The New England journal of medicine.
[26] C. Tournigand,et al. FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] W. Sutherland,et al. Gosha-jinki-gan (herbal medicine) in streptozocin-induced diabetic neuropathy , 1995, Journal of the Neurological Sciences.
[28] T. Onaya,et al. The effects of goshajinkigan, a herbal medicine, on subjective symptoms and vibratory threshold in patients with diabetic neuropathy. , 1994, Diabetes research and clinical practice.
[29] S Usuki,et al. Successful treatment of a senile diabetic woman with cataract with goshajinkigan. , 1991, The American journal of Chinese medicine.